Idea in Brief

The Challenge

Too often the boards of publicly traded companies are downright timid about science and technology.

The Reason

Most boards lack the expertise, the experience, and the organizational structure to identify developments in science and technology that can benefit their organizations.

The Solution

Board-level technology committees—working closely with senior management—can be powerful forces for exploration, innovation, and growth.

The boards of too many publicly traded companies are downright timid when considering matters involving science and technology. More often than not they focus on security and digitization—a defensive posture that overlooks the bigger opportunities emerging from new materials, space science, and a better understanding of the genome, to name just a few areas. It’s easy to be lulled into thinking that science doesn’t matter to a nontech company. But that distinction isn’t quite so meaningful when it comes to capitalizing on the technological change that is now ubiquitous, rapid, turbulent, and often emerging from increasingly unlikely corners.

A version of this article appeared in the September–October 2024 issue of Harvard Business Review.